ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

61.45 (USD) • At close March 13, 2025
Bedrijfsnaam ANI Pharmaceuticals, Inc.
Symbool ANIP
Munteenheid USD
Prijs 61.455
Beurswaarde 1,337,420,583
Dividendpercentage 0%
52-weken bereik 52.5 - 70.81
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Nikhil Lalwani
Website https://www.anipharmaceuticals.com

An error occurred while fetching data.

Over ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products,

Vergelijkbare Aandelen

Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc.

CRBU

0.986 USD

Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

IPSC

0.559 USD

Inhibrx, Inc. logo

Inhibrx, Inc.

INBX

14.15 USD

Cullinan Oncology, Inc. logo

Cullinan Oncology, Inc.

CGEM

8.92 USD

Intercept Pharmaceuticals, Inc. logo

Intercept Pharmaceuticals, Inc.

ICPT

19 USD

Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd.

NNOX

5.41 USD

Aura Biosciences, Inc. logo

Aura Biosciences, Inc.

AURA

7.26 USD

Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc.

TNGX

1.86 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)